অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medical specialties australia pty ltd - dextran 1 -

অস্ট্রেলিয়া - ইংরেজি - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron dextran complex - parenteral liquid/solution/suspension - iron dextran complex mineral-iron active 200.0 mg/ml - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - anaemia | iron deficiency | anaemia

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril - film coated tablet - 10 mg - active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

nv organon - vecuronium bromide - pdr+solv for soln for inj - 10 milligram

কানাডা - ইংরেজি - Health Canada

dextran products ltd. - iron (iron dextran complex) - liquid - 100mg - iron (iron dextran complex) 100mg - swine (pigs)

কানাডা - ইংরেজি - Health Canada

b. braun medical inc - dextran 70; sodium chloride - solution - 6%; 0.9% - dextran 70 6%; sodium chloride 0.9% - replacement preparations

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

actavis pharma, inc. - iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611) - ferric cation 50 mg in 1 ml - infed is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron. infed is contraindicated in patients who have demonstrated a previous hypersensitivity to iron dextran [see warnings and precautions ( 5.1 ) ] . risk summary   parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions ( 5.1 )] , which may have serious consequences, such as fetal bradycardia (see clinical considerations). advise pregnant persons of the potential risk to the fetus. available data from postmarketing reports with iron dextran use in pregnancy are insufficient to assess the risk of major birth defects or miscarriage. there are risks to the pregnant person and fetus associated with untreated iron deficiency anemia in pregnancy (see clinical considerations). iron dextran has been shown to be teratogenic and embryocidal in mice, rats, rabbi

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - dextran 70 (unii: 7sa290yk68) (dextran 70 - unii:7sa290yk68), hypromelloses (unii: 3nxw29v3wo) (hypromelloses - unii:3nxw29v3wo) - dextran 70 0.001 ml in 1 ml - uses - for the temporary relief of burning and irritation of the eye and for use as a protectant against further irritation. - for the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun. stop use and ask a doctor if - you feel eye pain - changes in vision occur - redness or irritation of the eye gets worse or lasts more than 72 hours. directions - instill 1 or 2 drops in the affected eye(s) as needed. - store at room temperature.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - ketorolac tromethamine 10 mg - carefully consider the potential benefits and risks of ketorolac tromethamine tablets and other treatment options before deciding to use ketorolac tromethamine tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. ketorolac tromethamine tablets are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with ketorolac tromethamine-iv or im and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine-iv/im and ketorolac tromethamine tablets is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administration and adve

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

h.j. harkins company, inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac tromethamine - unii:4eve5946bq) - ketorolac tromethamine 10 mg - carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac tromethamine. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. ketorolac tromethamine tablets are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with iv or im dosing of ketorolac tromethamine, and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine tablets and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings , precautions , dosage and administration , and adverse reactions ). patients should be switched to alternative analges